{"DataElement":{"publicId":"5215125","version":"1","preferredName":"Muscle Relaxant Preparation Agent Intravenous Administration Name","preferredDefinition":"The name of the muscle relaxant agent administered within or into a vein or veins prior to organ removal in order to relax skeletal muscles and reduce muscle contraction.","longName":"MUSCRLXT_IV_NAME","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5211153","version":"1","preferredName":"Muscle Relaxant Preparation Agent Intravenous Administration","preferredDefinition":"Synthetic compounds or mixtures with muscle relaxant activity. A muscle relaxant preparation is used to prevent muscle spasms by inhibiting muscle contractions and to relief pain associated with the spasms._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","longName":"5211151v1.0:2717633v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"5211151","version":"1","preferredName":"Muscle Relaxant Preparation Agent","preferredDefinition":"Synthetic compounds or mixtures with muscle relaxant activity. A muscle relaxant preparation is used to prevent muscle spasms by inhibiting muscle contractions and to relief pain associated with the spasms.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","longName":"C29891:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Muscle Relaxant Preparation","conceptCode":"C29891","definition":"Synthetic compounds or mixtures with muscle relaxant activity. A muscle relaxant preparation is used to prevent muscle spasms by inhibiting muscle contractions and to relief pain associated with the spasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FCA4553-9104-F44F-E050-BB89AD433B99","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2717633","version":"1","preferredName":"Intravenous Administration","preferredDefinition":"(in-tra-VEE-nus) IV. Within a blood vessel.:The act of administration.","longName":"C13346:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous","conceptCode":"C13346","definition":"Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42624FF7-0150-68FE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-28","modifiedBy":"ONEDATA","dateModified":"2007-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FCA4553-9112-F44F-E050-BB89AD433B99","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5212059","version":"1","preferredName":"Intravenous Muscle Relaxant Agent Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"5212059v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other Muscle Relaxants (specify)","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7E8D5-3232-5BAE-E050-BB89AD4321A3","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Suxamethonium chloride","valueDescription":"Succinylcholine Chloride","ValueMeaning":{"publicId":"3896166","version":"1","preferredName":"Succinylcholine Chloride","longName":"3896166","preferredDefinition":"The chloride salt form of succinylcholine, a quaternary ammonium compound and depolarizing agent with short-term muscle relaxant properties. Succinylcholine chloride binds to nicotinic receptors at the neuromuscular junction and opening the ligand-gated channels in the same way as acetylcholine, resulting in depolarization and inhibition of neuromuscular transmission. Depolarization may be prolonged due to succinylcholine's resistance to acetylcholinesterases thereby leading to disorganized muscle contraction followed by skeletal muscle relaxation and flaccid paralysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Succinylcholine Chloride","conceptCode":"C47730","definition":"The chloride salt form of succinylcholine, a quaternary ammonium compound and depolarizing agent with short-term muscle relaxant properties. Succinylcholine chloride binds to nicotinic receptors at the neuromuscular junction and opening the ligand-gated channels in the same way as acetylcholine, resulting in depolarization and inhibition of neuromuscular transmission. Depolarization may be prolonged due to succinylcholine's resistance to acetylcholinesterases thereby leading to disorganized muscle contraction followed by skeletal muscle relaxation and flaccid paralysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-930F-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FD7E8D5-3269-5BAE-E050-BB89AD4321A3","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"ONEDATA","dateModified":"2016-04-06","deletedIndicator":"No"},{"value":"Pancuronium","valueDescription":"Pancuronium","ValueMeaning":{"publicId":"5227213","version":"1","preferredName":"Pancuronium","longName":"5227213","preferredDefinition":"A synthetic, long-acting bis-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity. Pancuronium competitively binds to and blocks the nicotinic acetylcholine receptor at the neuromuscular junction, thereby preventing acetylcholine (ACh) binding and resulting in skeletal muscle relaxation and paralysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancuronium","conceptCode":"C61876","definition":"A synthetic, long-acting bis-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity. Pancuronium competitively binds to and blocks the nicotinic acetylcholine receptor at the neuromuscular junction, thereby preventing acetylcholine (ACh) binding and resulting in skeletal muscle relaxation and paralysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-18F6-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-190E-8EE5-E050-BB89AD433C11","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"},{"value":"Vercuronium","valueDescription":"Vercuronium","ValueMeaning":{"publicId":"5227214","version":"1","preferredName":"Vercuronium","longName":"5227214","preferredDefinition":"A synthetic, intermediate-acting mono-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity. Vecuronium competitively binds to and blocks the nicotinic acetylcholine receptor at the neuromuscular junction, thereby preventing acetylcholine (ACh) binding and resulting in skeletal muscle relaxation and paralysis. Vecuronium has a shorter duration of action than pancuronium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vecuronium","conceptCode":"C87317","definition":"A synthetic, intermediate-acting mono-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity. Vecuronium competitively binds to and blocks the nicotinic acetylcholine receptor at the neuromuscular junction, thereby preventing acetylcholine (ACh) binding and resulting in skeletal muscle relaxation and paralysis. Vecuronium has a shorter duration of action than pancuronium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-191B-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-1933-8EE5-E050-BB89AD433C11","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FD7E8D5-3212-5BAE-E050-BB89AD4321A3","latestVersionIndicator":"Yes","beginDate":"2016-04-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-06","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736434","version":"1","longName":"Lung Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736433","version":"1","longName":"Kidney Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736432","version":"1","longName":"Colon Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736435","version":"1","longName":"Ovary Sugery-Anesthesia","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"IV Muscle Relaxants","type":"Preferred Question Text","description":"IV Muscle Relaxants","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FEA0C5F-1947-F37D-E050-BB89AD43280F","latestVersionIndicator":"Yes","beginDate":"2016-04-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-07","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}